Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume $12.03 -0.22 (-1.80%) As of 10:03 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Finch Therapeutics Group Short Interest DataFinch Therapeutics Group (FNCH) has a short interest of 100 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2,182 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.20 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,606,000 sharesShort Percent of Float0.01%Today's Trading Volume187 sharesAverage Trading Volume2,182 sharesToday's Volume Vs. Average9% Short Selling Finch Therapeutics Group? Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFNCH Short Interest Over TimeFNCH Days to Cover Over TimeFNCH Percentage of Float Shorted Over Time Finch Therapeutics Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025100 shares $1.20 thousand No Change0.0%0 $12.03 7/15/2025100 shares $1.28 thousand No ChangeN/A0.1 $12.75 6/30/2025100 shares $1.32 thousand -88.9%0.0%0 $13.20 6/15/2025900 shares $12.38 thousand No Change0.1%0.6 $13.75 5/31/2025900 shares $12.15 thousand +12.5%0.1%0.3 $13.50 5/15/2025800 shares $10.57 thousand -11.1%N/A0.2 $13.21 4/30/2025900 shares $11.25 thousand -18.2%N/A0.1 $12.50 4/15/20251,100 shares $14.63 thousand -31.3%N/A0.3 $13.30 3/14/20251,600 shares $21.84 thousand No ChangeN/A0.3 $13.65 2/28/20251,600 shares $25.26 thousand -36.0%N/A0.4 $15.79 Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 2/14/20252,500 shares $37.50 thousand +66.7%N/A0.3 $15.00 1/31/20251,500 shares $16.88 thousand No ChangeN/A0.8 $11.25 1/15/20251,500 shares $16.37 thousand -6.3%N/A0.9 $10.91 5/15/202419,200 shares $40.32 thousand -27.3%2.8%0.3 $2.10 4/30/202426,400 shares $61.78 thousand +149.1%4.9%0.5 $2.34 4/15/202410,600 shares $23.80 thousand +15.2%2.0%0.2 $2.25 3/31/20249,200 shares $23.92 thousand -20.7%1.7%0.5 $2.60 3/15/202411,600 shares $29.64 thousand +383.3%2.2%0.6 $2.56 2/29/20242,400 shares $6.24 thousand -27.3%0.5%0.1 $2.60 2/15/20243,300 shares $8.25 thousand +65.0%0.6%0.1 $2.50 1/31/20242,000 shares $5.50 thousand +300.0%0.4%0.1 $2.75 1/15/2024500 shares $1.56 thousand -73.7%0.1%0 $3.11 12/31/20231,900 shares $6.86 thousand -65.5%0.4%0.1 $3.61 12/15/20235,500 shares $18.92 thousand -61.3%1.0%0.3 $3.44 11/30/202314,200 shares $61.06 thousand -27.9%2.5%1.7 $4.30 11/15/202319,700 shares $79.00 thousand -3.9%3.4%2.8 $4.01 10/31/202320,500 shares $79.54 thousand -11.6%3.6%2.8 $3.88 10/15/202323,200 shares $103.94 thousand -4.1%4.1%2.6 $4.48 9/30/202324,200 shares $125.36 thousand -15.1%4.3%2.5 $5.18 9/15/202328,500 shares $163.59 thousand +27.2%5.1%2.7 $5.74 8/31/202322,400 shares $144.70 thousand +4.7%4.0%0.6 $6.46 8/15/202321,400 shares $133.96 thousand +57.4%3.8%0.6 $6.26 7/31/202313,600 shares $104.18 thousand -20.0%0.1%0.4 $7.66 7/15/202317,000 shares $155.89 thousand -25.4%0.1%0.5 $9.17 6/30/202322,800 shares $194.48 thousand -20.8%4.0%0.6 $8.53 6/15/202328,800 shares $249.12 thousand -73.1%5.1%0.8 $8.65 5/31/2023106,900 shares $897.96 thousand +73.5%0.6%0.4 $8.40 5/15/202361,600 shares $22.27 thousand -73.3%0.4%0.2 $0.36 4/30/2023230,300 shares $92.86 thousand +83.1%1.4%0.8 $0.40 4/15/2023125,800 shares $49.36 thousand +47.0%0.7%0.4 $0.39Capital Gains Tax Strategies for Seniors (Ad)Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.Click here to see the three strategies and get matched with a financial advisor today. 3/31/202385,600 shares $33.64 thousand -9.9%0.5%0.5 $0.39 3/15/202395,000 shares $35.15 thousand -51.7%0.6%0.5 $0.37 2/28/2023196,500 shares $81.35 thousand +10.2%1.2%1.2 $0.41 2/15/2023178,400 shares $75.12 thousand +49.8%1.1%1.1 $0.42 1/31/2023119,100 shares $59.55 thousand -4.4%0.7%0.9 $0.50 1/15/2023124,600 shares $69.78 thousand +22.4%0.8%1.2 $0.56 12/30/2022101,800 shares $48.86 thousand +27.4%0.6%1.4 $0.48 12/15/202279,900 shares $64.71 thousand +6.4%0.5%1.3 $0.81 11/30/202275,100 shares $73.61 thousand -17.7%0.5%1.8 $0.98 11/15/202291,300 shares $98.44 thousand -17.9%0.6%2.1 $1.08 10/31/2022111,200 shares $144.56 thousand -6.1%0.7%2.5 $1.30 10/15/2022118,400 shares $188.26 thousand -21.0%0.7%2.6 $1.59 9/30/2022149,900 shares $250.33 thousand +19.6%1.0%3.2 $1.67 9/15/2022125,300 shares $334.55 thousand -12.7%0.8%2 $2.67 8/31/2022143,600 shares $310.18 thousand -37.9%1.0%2 $2.16 8/15/2022231,400 shares $647.92 thousand -19.6%1.5%2.8 $2.80 7/31/2022287,700 shares $561.02 thousand +0.6%1.9%2.4 $1.95 7/15/2022285,900 shares $651.85 thousand -24.5%1.9%0.3 $2.28 6/30/2022378,600 shares $1.08 million -41.3%2.5%0.4 $2.84 6/15/2022644,700 shares $1.75 million -14.1%4.3%0.7 $2.71 5/31/2022750,800 shares $1.78 million -0.6%5.0%0.8 $2.37 5/15/2022755,200 shares $1.68 million +296.0%5.0%0.8 $2.23 4/30/2022190,700 shares $482.47 thousand +2.3%1.3%0.2 $2.53 4/15/2022186,500 shares $760.92 thousand -13.1%1.2%5.3 $4.08 3/31/2022214,500 shares $1.08 million -9.0%1.4%6.3 $5.03 3/15/2022235,700 shares $1.22 million -6.5%1.6%5.7 $5.17 2/28/2022252,200 shares $2.11 million -0.4%1.7%3.5 $8.37 2/15/2022253,100 shares $2.21 million -0.5%1.7%3 $8.75 1/31/2022254,300 shares $2.16 million +9.9%1.5%2.5 $8.48 1/15/2022231,400 shares $2.11 million -8.9%1.4%2.1 $9.10 12/31/2021253,900 shares $2.53 million +58.1%1.5%2.3 $9.97 12/15/2021160,600 shares $1.52 million -30.5%1.0%1.5 $9.47 11/30/2021231,100 shares $3.84 million +22.5%1.4%2.9 $16.62 11/15/2021188,700 shares $2.74 million +0.4%1.1%3.1 $14.54 10/29/2021187,900 shares $2.52 million -19.1%1.1%4 $13.40 10/15/2021232,200 shares $2.77 million -2.6%1.4%6.8 $11.95 9/30/2021238,300 shares $3.10 million -2.4%1.4%5 $13.00 9/15/2021244,100 shares $3.38 million -16.6%1.5%3.7 $13.83 8/31/2021292,800 shares $4.14 million -31.0%1.8%4 $14.15 8/13/2021424,600 shares $5.58 million No Change2.5%5.7 $13.15 FNCH Short Interest - Frequently Asked Questions What is Finch Therapeutics Group's current short interest? Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 100 shares of FNCH short. 0.01% of Finch Therapeutics Group's shares are currently sold short. Learn More on Finch Therapeutics Group's current short interest. What is a good short interest percentage for Finch Therapeutics Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Finch Therapeutics Group's floating shares are currently sold short. How does Finch Therapeutics Group's short interest compare to its competitors? 0.01% of Finch Therapeutics Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Finch Therapeutics Group: Forte Biosciences, Inc. (1.17%), Context Therapeutics Inc. (2.09%), Assertio Holdings, Inc. (5.70%), Sutro Biopharma, Inc. (4.14%), Pyxis Oncology, Inc. (10.68%), IGM Biosciences, Inc. (2.56%), BeyondSpring Inc. (7.37%), Metagenomi, Inc. (6.38%), Applied Therapeutics Inc. (7.02%), Invivyd, Inc. (4.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Finch Therapeutics Group stock? Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. FNCH shares are trading down $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Finch Therapeutics Group? A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further. How often is Finch Therapeutics Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies FBRX Short Squeeze CNTX Short Squeeze ASRT Short Squeeze STRO Short Squeeze PYXS Short Squeeze IGMS Short Squeeze BYSI Short Squeeze MGX Short Squeeze APLT Short Squeeze IVVD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FNCH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access